KAT5 and hepatocellular carcinoma: Importantly, we uncovered a novel mechanism that O-GlcNAcylation of KAT5, as a transcriptional regulator, epigenetically activates TWIST1 via enhancing histone H4 acetylation on the TWIST1 promoter, thereby inhibiting E-cadherin expression in PCK1-deficient hepatoma cells.